Prehospital Glucose Testing for Children with Seizures: A Proposed Change in Management

Prehospital Emergency Care
|September 17, 2016
PubMed

Insights

Hypoglycemia is rare in pediatric seizures, making universal field blood glucose testing (BGT) in Emergency Medical Services (EMS) protocols less useful. Reassessing these protocols may improve patient care.

Area of Science:

  • Pediatric Emergency Medicine
  • Clinical Diagnostics
  • Neurology

Background:

  • Emergency Medical Services (EMS) often mandate blood glucose testing (BGT) for pediatric patients with seizures or altered consciousness.
  • Limited data exist on the diagnostic yield of BGT in all pediatric seizures, irrespective of initial mental status.

Purpose of the Study:

  • To determine the prevalence of hypoglycemic seizures in pediatric patients presenting with prehospital seizures.
  • To evaluate the utility of repeat BGT in the emergency department (ED) for these patients.

Main Methods:

  • Retrospective analysis of pediatric patients (≤14 years) with prehospital seizures transported by EMS over two years.
  • Inclusion criteria: witnessed seizures in the field. Data reviewed: prehospital and ED records, blood glucose levels, Glasgow Coma Scale (GCS), mental status, age, sex, medical history, and outcomes.
  • Hypoglycemia defined as blood glucose <60 mg/dL.

Main Results:

  • Out of 770 pediatric seizure patients, only 0.5% had documented field hypoglycemia, with two receiving treatment.
  • One patient was normoglycemic in the field but hypoglycemic in the ED, requiring no intervention.
  • The most common discharge diagnosis was simple febrile seizure (38.6%).

Conclusions:

  • Hypoglycemia is exceptionally rare in pediatric seizure patients, indicating low utility for universal field BGT.
  • Findings suggest a need to reassess current prehospital seizure protocols and explore a novel evaluation algorithm.
  • Further research with larger sample sizes is recommended to validate findings and identify specific indications for glucose testing.
Abstract

Related Concept Videos

Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.1K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.6K
Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
5.0K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.3K
Oral Hypoglycemic Agents: Glinides01:06

Oral Hypoglycemic Agents: Glinides

Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
804
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
28.0K